CHAAN S NG to Lung Neoplasms
This is a "connection" page, showing publications CHAAN S NG has written about Lung Neoplasms.
Connection Strength
0.722
-
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors. J Comput Assist Tomogr. 2018 May/Jun; 42(3):357-364.
Score: 0.125
-
Observer Variability in CT Perfusion Parameters in Primary and Metastatic Tumors in the Lung. Technol Cancer Res Treat. 2018 01 01; 17:1533034618769767.
Score: 0.122
-
Effect of duration of scan acquisition on CT perfusion parameter values in primary and metastatic tumors in the lung. Eur J Radiol. 2013 Oct; 82(10):1811-8.
Score: 0.089
-
Effect of sampling frequency on perfusion values in perfusion CT of lung tumors. AJR Am J Roentgenol. 2013 Feb; 200(2):W155-62.
Score: 0.087
-
Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors. AJR Am J Roentgenol. 2011 Jul; 197(1):113-21.
Score: 0.078
-
Semiautomated motion correction of tumors in lung CT-perfusion studies. Acad Radiol. 2011 Mar; 18(3):286-93.
Score: 0.076
-
Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol. 2010 Feb; 194(2):W134-40.
Score: 0.070
-
Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors. Comput Med Imaging Graph. 2016 Mar; 48:1-8.
Score: 0.026
-
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer. Invest New Drugs. 2010 Oct; 28(5):634-40.
Score: 0.017
-
Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging. 2008 Sep; 28(3):791-6.
Score: 0.016
-
Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003 Oct 01; 98(7):1457-64.
Score: 0.011
-
Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol. 2013 Oct; 36(5):450-4.
Score: 0.006